antibiot
one
major
agent
wide
use
clinic
practic
prevent
treatment
infect
howev
irrat
antibiot
use
also
becom
common
issu
worldwid
result
rise
exacerb
antibiot
resist
lead
declin
clinic
efficaci
increas
advers
reaction
irrat
antibiot
use
present
enorm
challeng
infect
control
hospit
world
health
organ
consid
bacteri
resist
one
healthcar
issu
sever
threaten
human
life
similarli
china
also
face
larg
threat
antibiot
use
enhanc
manag
antimicrobi
agent
ministri
health
moh
peopl
republ
china
releas
nationwid
special
campaign
antibiot
stewardship
program
asp
conduct
specif
rectif
irrat
antibiot
use
china
studi
investig
analyz
chang
relev
indic
antibiot
use
medic
organ
tertiari
hospit
secondari
hospit
attempt
evalu
effect
specif
activ
control
antibiot
use
secondari
tertiari
hospit
tianjin
china
special
antibiot
use
rectif
program
initi
novemb
china
present
studi
antibiot
use
data
collect
inpati
medic
record
year
defin
cycl
april
year
start
consecut
year
ie
april
april
april
base
quasiexperiment
studi
qualiti
manag
system
qm
plandocheckact
pdca
manag
concept
antibiot
use
indic
assess
analyz
compar
chang
among
cycl
clinic
investig
conduct
public
hospit
includ
tertiari
gener
hospit
secondari
gener
hospit
tianjin
one
directli
control
municip
china
use
antibiot
hospit
summar
analysi
valid
hospit
record
hospit
durat
day
collect
hospit
data
antibiot
consumpt
normal
defin
daili
dose
ddd
day
inpati
total
case
includ
studi
accord
requir
nationwid
special
campaign
antibiot
stewardship
program
asp
percentag
antibiot
use
inpati
case
gener
hospit
exceed
antimicrobi
use
densiti
aud
gener
hospit
must
control
defin
daili
dose
ddd
per
patient
day
moreov
percentag
antibiot
prescript
given
emerg
patient
exceed
proport
prophylact
antibiot
use
patient
undergo
type
incis
surgeri
exceed
final
preoper
inpati
prophylact
antibiot
use
perform
h
surgeri
except
cesarean
section
antibiot
select
treatment
cours
must
ration
durat
prophylact
antibiot
use
undergo
type
incis
oper
must
control
within
h
studi
protocol
approv
ethic
committe
tianjin
medic
univers
inform
consent
obtain
particip
percentag
antibiot
use
inpati
number
patient
use
antibiot
dischargetot
number
patient
discharg
period
aud
defin
ddd
per
patient
day
calcul
use
equat
aud
total
antibiot
consumpt
cumul
ddd
amount
averag
length
hospit
staytot
number
patient
persontim
discharg
hospit
period
proport
prophylact
antibiot
use
type
incis
number
case
prophylact
use
type
incis
surgerytot
number
type
incis
surgeri
complianc
rate
ration
antibiot
use
h
type
incis
surgeri
number
case
use
antibiot
prophylaxi
h
type
incis
surgerytot
number
case
use
antibiot
prophylaxi
type
incis
surgeri
period
complianc
rate
antibiot
prophylact
use
h
patient
receiv
type
incis
surgeri
number
case
h
antibiot
prophylaxi
type
incis
surgerytot
number
case
receiv
antibiot
prophylaxi
type
incis
surgeri
period
antibiot
stewardship
program
asp
led
work
group
infect
qualiti
control
center
tianjin
health
bureau
work
group
compos
expert
epidemiolog
clinic
expert
data
verif
personnel
local
resid
work
group
examin
clinic
use
antibacteri
drug
april
april
april
hospit
notif
made
case
unreason
antibiot
use
train
also
perform
infect
specialist
doctor
pharmacist
carri
asp
total
doctor
pharmacist
train
period
multidisciplinari
team
clinic
profession
special
infecti
diseas
critic
care
medicin
microbiolog
disinfect
isol
pharmacolog
particip
profession
confer
seminar
train
cours
varieti
area
discuss
indepth
studi
profession
could
effect
master
cuttingedg
inform
industri
chang
workplac
experi
thu
abl
play
vital
role
correctli
diagnos
infecti
patient
hospit
properli
treat
infecti
patient
enhanc
prevent
control
infect
hazard
hospit
set
clinic
train
provid
multidisciplinari
team
expert
area
infect
control
refractori
diseas
strategi
periop
antibiot
prophylaxi
laboratorytoclin
microbiolog
commun
condit
initi
hospit
visit
acquir
immun
defici
syndrom
aid
patient
protect
medic
staff
basic
principl
antibiot
use
guidelin
clinic
antibiot
use
infecti
diseas
addit
improv
diagnosi
treatment
infect
train
cours
provid
follow
area
acquisit
common
infecti
diseas
longterm
hospit
monitor
accumul
infecti
diseas
known
unknown
sourc
construct
infect
prevent
softwar
hardwar
moreov
clinic
train
also
includ
cours
advantag
hand
wash
efficaci
use
alcohol
hand
rub
cours
interest
cover
establish
temporari
quarantin
zone
newli
admit
patient
recent
advanc
environment
disinfect
infect
result
unsanitari
hospit
environ
preval
trend
novel
middl
east
coronaviru
infect
gener
increas
nosocomi
infect
relat
surgeryinduc
patient
hypothermia
antibiot
prescript
analyz
assess
infect
expert
hospit
qualiti
control
center
onsit
feedback
provid
hospit
regard
sever
issu
antibiot
use
includ
overus
presenc
name
redund
gener
formula
drug
select
distribut
challeng
specif
drug
bias
lack
firstgener
cephalosporin
surgic
prophylaxi
hierarch
catalogu
whether
surgic
prophylact
antibiot
eg
aztreonam
cefoxitin
ceftriaxon
includ
catalogu
number
measur
introduc
tianjin
sinc
initi
asp
campaign
implement
hierarchi
manag
clinic
antibiot
use
promot
scientif
ration
antibiot
use
reduc
antibiot
resist
ensur
safeti
medic
servic
done
accomplish
antibiot
prophylaxi
ration
diagnosi
treatment
infecti
diseas
addit
nosocomi
infect
infecti
outbreak
gener
hospit
monitor
via
antibiot
use
resist
surveil
network
prescript
medic
order
identifi
computerassist
electron
prescript
system
integr
clinic
patient
data
basic
medic
inform
pathogen
spectrum
infect
electron
prescript
system
increas
rate
standard
prescript
use
inform
technolog
develop
trend
standard
manag
longterm
strategi
achiev
ration
antibiot
use
clinic
set
antibiot
consumpt
data
provid
hospit
tianjin
tianjin
center
nosocomi
infect
control
review
check
relev
hospit
infect
data
statist
analysi
perform
use
spss
softwar
version
ratio
antibiot
use
hospit
patient
mainli
present
percentag
repeat
measur
analysi
varianc
conduct
comparison
among
group
pvalu
consid
statist
signific
percentag
antibiot
use
inpati
aud
tertiari
hospit
reduc
ddd
ddd
respect
proport
prophylact
antibiot
applic
type
incis
oper
decreas
percentag
antibiot
prophylaxi
h
surgeri
except
cesarean
section
increas
complianc
rate
antibiot
prophylact
use
h
patient
type
incis
surgeri
gener
hospit
significantli
increas
p
tabl
percentag
antibiot
use
inpati
aud
reduc
ddd
ddd
respect
proport
prophylact
antibiot
applic
type
incis
oper
decreas
percentag
antibiot
prophylaxi
h
surgeri
except
cesarean
section
increas
complianc
rate
antibiot
prophylact
use
h
patient
type
incis
surgeri
improv
chang
statist
signific
p
except
chang
time
antibiot
prophylaxi
patient
receiv
type
incis
oper
tabl
antibiot
resist
newli
emerg
issu
yet
becom
increasingli
threaten
although
antibiot
resist
phenomenon
occur
natur
development
process
irrat
antibiot
use
acceler
emerg
antibiot
resist
educ
clinic
manag
antibiot
use
becom
strong
measur
control
bacteri
resist
global
control
monitor
prescript
preauthor
antibiot
use
causal
analysi
irrat
antibiot
use
perform
chines
govern
signific
improv
made
specif
rectif
antibiot
use
result
indic
antibiot
use
show
decreas
trend
complianc
rate
ration
antibiot
use
increas
annual
inappropri
antibiot
select
doctor
misunderstand
drug
indic
influenc
misus
antibiot
treat
viral
infect
rather
bacteri
infect
nation
preval
survey
hospit
infect
antibiot
use
britain
point
gener
antibiot
use
rate
intens
care
unit
highest
antibiot
use
rate
use
antibiot
surgeri
studi
shown
antibiot
use
unreason
unseason
use
result
rise
antibiot
resist
prolong
hospit
increas
medic
expens
mexico
brazil
use
promulg
polici
restrict
antibiot
sale
restrict
antibiot
use
influenc
use
nonsteroid
antiinflammatori
drug
analges
drug
addit
intervent
studi
show
educ
train
pharmacist
promot
ration
use
vancomycin
intens
care
unit
icu
unreason
antibiot
use
control
educ
train
clinician
clinic
pharmacist
nurs
medic
staff
knowledg
antibiot
need
improv
moreov
antibiot
prescrib
base
experi
rather
pathogen
laboratori
examin
indic
low
rate
analys
antibiot
prescrib
desir
patient
famili
avoid
doctorpati
disput
furthermor
misunderstand
occur
respect
public
knowledg
antibiot
use
includ
misinterpret
antibiot
equival
antiinflammatori
agent
misunderstood
concept
antibiot
exagger
efficaci
abus
via
direct
purchas
overthecount
drug
store
survey
household
medic
china
show
resid
habit
stock
antibiot
resid
medic
famili
member
treatment
inflamm
cold
fever
antibiot
use
depart
improv
special
comprehens
manag
program
train
ration
antibiot
use
enhanc
strictli
control
drug
indic
administr
determin
frequenc
antibiot
use
base
pharmacokinet
featur
follow
principl
minimum
effect
dose
shortest
treatment
cours
antibiot
use
guid
result
bacteri
cultur
drug
suscept
test
scientif
effici
pragmat
advanc
manag
antibiot
use
accomplish
implement
longterm
scientif
comprehens
manag
system
base
inform
technolog
system
monitor
nosocomi
infect
outbreak
gener
hospit
via
clinic
antibiot
use
resist
surveil
network
combin
computerassist
electron
prescript
system
strategi
achiev
highli
effici
scientif
pragmat
manag
antibiot
use
reduc
length
hospit
stay
decreas
misus
healthcar
resourc
delay
antibiot
resist
result
antibiot
resist
monitor
asp
reveal
resist
pseudomona
aeruginosa
carbapenem
meropenem
continu
declin
tertiari
secondari
hospit
latter
decreas
drug
resist
acinetobact
baumannii
decreas
evidenc
reduct
meropenem
resist
sinc
implement
asp
campaign
antibiot
resist
acinetobact
baumannii
declin
repres
signific
reduct
blactam
resist
resist
reduct
fluoroquinolon
aminoglycosid
consist
result
report
anoth
domest
studi
overal
resist
pseudomona
aeruginosa
decreas
meropenem
ciprofloxacin
imipenem
period
studi
sinc
initi
asp
campaign
april
tianjin
ration
antibiot
use
improv
establish
prescript
assess
system
antibiot
cost
reduc
million
rmb
cumul
million
rmb
cours
studi
current
goal
ration
antibiot
use
larg
achiev
urban
area
signific
improv
made
region
collabor
effort
control
health
administr
depart
profession
societi
diseas
control
center
medic
institut
insur
sector
limit
studi
target
overal
antibiot
use
gener
hospit
without
detail
explor
antibiot
use
special
field
intern
medicin
surgeri
obstetr
gynecolog
pediatr
intens
care
howev
base
develop
trend
asp
campaign
rel
satisfactori
outcom
accomplish
manag
antibiot
use
china
antibiot
use
manag
complic
issu
longterm
challeng
signific
improv
achiev
antibiot
use
tianjin
asp
campaign
although
continu
effort
requir
consolid
enhanc
improv
normal
ration
antibiot
use
futur
work
